ASCO Annual Meeting 2022: Neue Daten zu Antikörper-Drug-Konjugaten (ADCs) und CDK4/6-Inhibitoren beim metastasierten Mammakarzinom | Zendy

AI Assistant Blog Pricing

Open Access

ASCO Annual Meeting 2022: Neue Daten zu Antikörper-Drug-Konjugaten (ADCs) und CDK4/6-Inhibitoren beim metastasierten Mammakarzinom

Author(s) -

Gerhard Emrich

Publication year - 2022

Publication title -

oncology research and treatment

Language(s) - German

Resource type - Journals

SCImago Journal Rank - 0.553

H-Index - 48

eISSN - 2296-5262

pISSN - 2296-5270

DOI - 10.1159/000525714

Subject(s) - medicine , gynecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.